Smoking and Hypertension

References

• Stamler J., Neaton J. D., Wentworth D. N. Blood pressure (systolic and diastolic) and risk of fatal coronary heart disease. Hypertension 1989; 13(suppl I)I-2-I–12
   Google Scholar
• Shaper A. G., Pocock S. J., Walker M., Phillips A. N., Whitehead T. P., Macfarlane P. W. Risk factors for ischaemic heart disease: the prospective phase of the British Heart Study. J Epid and Comm Health 1985; 39: 197–209
   PubMed Web of Science ®Google Scholar
• Shaper A. G., Pocock S. J., Walker M., Cohen N. M., Wale C. J., Thomson A. G. British Regional Heart Study: cardiovascular risk factors in middle-aged men in 24 towns. Br Med J 1981; 283: 179–186
   PubMed Web of Science ®Google Scholar
• Fulton M., Thomson M., Elton R. A., Brown S., Wood D. A., Oliver F. Cigarette smoking, social class and nutrient intake: relevance to coronary heart disease. Eur J Clin Nutr 1988; 42: 797–903
   PubMed Web of Science ®Google Scholar
• Wack J. T., Rodin J. Smoking and its effects on body weight and the systems of caloric regulation. Am J Clin Nutr 1982; 35: 366–80
   PubMed Web of Science ®Google Scholar
• Halkin H., Or J., Fuchs Z., Lusky A., Chetrit A., Modan M. Smoking accounts for adverse effect of antihypertensive medications on plasma lipids. A Population-Based Study. Hypertension 1989; 14: 210–217
   PubMed Web of Science ®Google Scholar
• Doll R. Prospects for prevention. Br Med J 1983; 286: 445–453
   PubMed Web of Science ®Google Scholar
• Goldhaber S. Z., Manson J. E., Stampfer M., Motte F., Rosner B., Buring J. E., Hennekens C. H. Low-dose aspirin and subsequent peripheral arterial surgery in the Physicians' Health Study. The Lancet 1992; 340: 143–145
   PubMed Web of Science ®Google Scholar
• Manson J. E., Tosteson H., Ridker P. M., Satterfield S., Hebert P., Oconnor G. T., Buring J. E., Hennekens C. H. The primary prevention of myocardial infarction. New Eng J Med 1992; 326: 1406–16
   PubMed Web of Science ®Google Scholar
• Meade T. W., Imeson J., Stirling Y. Effects of changes in smoking and other characteristics on clotting factors and the risk of ischaemic heart diseases. Lancet 1987; ii: 986–8
   Google Scholar
• Green M. S., Jucha E., Luz Y. Blood pressure in smokers and nonsmokers: epidemiologic findings. Am Heart J 1986; 111: 932–40
   PubMed Web of Science ®Google Scholar
• Benowitz H. L. Pharmacologic aspects of cigarette smoking and nicotine addiction. New Eng J Med 1988; 319: 1318–30
   PubMed Web of Science ®Google Scholar
• Freestone S., Ramsay L. E. Effect of coffee and cigarette smoking on the blood pressure of untreated and diuretic-treated hypertensive patients. Am J Med 1982; 73(3)348–53
   PubMed Web of Science ®Google Scholar
• Grobbee D. E., Rimm E. B., Giovannucci E., Colditz G., Stampfer M., Willett W. Coffee, caffeine, and cardiovascular disease in men. New Eng J Med 1990; 323: 1026–32
   PubMed Web of Science ®Google Scholar
• Qizilbash N., Jones L., Warlow C., Mann J. Fibrinogen and lipid concentrations as risk factors for transient ischaemic attacks and minor ischaemic strokes. Br Med J 1991; 303: 605–9
   PubMed Web of Science ®Google Scholar
• Yarnell J. W.G., Baker I. A., Sweetnam P. Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. The Caerphilly and Speedwell Collaborative Heart Disease Studies. Circulation 1991; 83: 836–44
   PubMed Web of Science ®Google Scholar
• La Croix A. Z., Lang J., Scherr P., Wallace R., Huntley J., Berkman L., Curb J. D., Evans D., Hennekens C. H. Smoking and mortality among older men and women in three communities. New Eng J Med 1991; 324: 1619–25
   PubMed Web of Science ®Google Scholar
• Willett W. C., Green A., Stampfer M. J., Speizer F. E., Colditz G. A., Rosner B., Monson R. R., Stason W., Hennekens C. H. Relative and absolute excess risks of coronary heart disease among women who smoke cigarettes. New Eng J Med 1987; 317: 1303–9
   PubMed Web of Science ®Google Scholar
• Castelli W. P., Garrison R. J., Dawber T., Namara P. M., Feinleib M., Kannel W. B. The filter cigarette and coronary heart disease: the Framingham study. Lancet 1981; ii: 109–113
   Web of Science ®Google Scholar
• Rosengren A., Welin L., Tsipogianni A., Wilhelmsen L. Impact of cardiovascular risk factors on coronary heart disease and mortality among middle aged diabetic men: a general population study. Br Med J 1989; 299: 1127–31
   PubMed Web of Science ®Google Scholar
• Yudkin J. S. How can we best prolong life? Benefits of coronary risk factor reduction in non-diabetic and diabetic subjects. Br Med J 1993; 306: 131–8
   Web of Science ®Google Scholar
• Stampfer M. J., Willett W. C., Colditz G. A., Speizer F. E., Hennekens C. H. A prospective study of past use of oral contraceptive agents and risk of cardiovascular diseases. N Engl J Med 1988; 319: 1313–7
   PubMed Web of Science ®Google Scholar
• Lidegaard O. Oral contraception and risk of a cerebral thrmoboembolic attack: results of a case-control study. Br Med J 1993; 306: 956–63
   PubMed Web of Science ®Google Scholar
• Mac Mahon B., Trichopoulos D., Cole P., Brown J. Cigarette smoking and urinary estrogens. N Engl J Med 1982; 307: 1062–5
   PubMed Web of Science ®Google Scholar
• Davis R. M. Current trends in cigarette advertising and marketing. N Engl J Med 1987; 316: 725–32
   PubMed Web of Science ®Google Scholar
• Clark PB, Pert A. Autoradiographic evidence for nicotine receptors on nigrostriatal and mesolimbic dopaminergic neurons. Brain Res. 1985; 348: 355–8
   PubMed Web of Science ®Google Scholar
• Sleight P. Cardiac vomiting. Brit. Heart J. 1981; 46: 5–7
   PubMedGoogle Scholar
• Medical Research Council Working Party. MRC trial of treatment of mild hypertension: principal results. Br Med J 1985; 291: 97–104
   PubMed Web of Science ®Google Scholar
• The IPPPSH Collaborative Group. Cardiovascular risk and risk factors in a randomized trial of treatment based on the beta-blocker oxprenolol: The International Prospective Primary Prevention Study in Hypertension (IPPPSH). J Hyper 1985; 3: 379–392
   Web of Science ®Google Scholar
• Trap-Jensen J., Carlsen J. E., Svendsen T. L., Christensen N. J. Cardiovascular and adrenergic effects of cigarette smoking during immediate non-selective and selective beta adrenoceptor blockade in humans. Eur J Clin Invest 1979; 9: 181–3
   PubMed Web of Science ®Google Scholar
• Wilhelmson L., Berglund G., Elmfeldt D., et al. Beta blockers versus diuretics in hypertensive men. Main results from the HAPPHY trial. J Hyper 1987; 5: 561–572
   Web of Science ®Google Scholar
• Wikstrand J., Warnold I., Olsson G. Primary prevention with metoprolol in patients with hypertension. Mortality results from the MAPHY study. J Am Med Assoc 1988; 259: 1976–1982
   PubMed Web of Science ®Google Scholar
• Rosman J., Weidmann P., Antihypertensive P. drugs and serum lipoproteins in “Lipoprotein Metabolism and Lipid-Lowering Therapy: The State of the Art”, D. Betteridge, G. Gregor, P. S. Sever. Gardiner-Caldwell Communications Ltd., Macclesfield 1990; 129–139
   Google Scholar
• Klemp P, Staberg B, Madsbad S, Kølendorf K. Smoking reduces insulin absorption from subcutaneous tissue. Br, Med. J. 1982; 284: 237
   PubMed Web of Science ®Google Scholar
• Woolf N. Cigarette smoking and atherosclerosis. Smoking and arterial disease, R. Greenhalgh. Pitman Medical, Bath 1981; 46–59
   Google Scholar
• Noronha-Dutra A. A., Epperlein M. M., Woolf N. Effect of cigarette smoking on cultured human endothelial cells. Cardiovasc Res 1993; 27: 774–778
   PubMed Web of Science ®Google Scholar
• Hunninghake G. W., Crystal R. G. Cigarette smoking and lung destruction: accumulation of neutrophils in the lungs of cigarette smokers. Am Rev Respir Dis 1983; 128: 833–8
   PubMed Web of Science ®Google Scholar
• Peto R., Lopez A. D., Boreham J., Thun M., Heath C. Mortality from tobacco in developed countries: indirect estimation from national vital statistics. Lancet 1992; 339: 1268–78
   PubMed Web of Science ®Google Scholar